A research team from the Technion's Wolfson Faculty of Chemical Engineering has developed an original technology for treating ...
Treating breast cancer remains a major medical challenge worldwide. This is largely due to the ability of breast cancer cells ...
Breast cancer is becoming increasingly treatable, but in some cases the disease can resurface even decades after a patient has been declared cancer free. This is because of cells that detach from the ...
Scientists at Pune's Agharkar Research Institute developed a nanomedicine targeting breast cancer cells by silencing key ...
A team at IIT BHU led by Professor Vikas Kumar Dubey has identified a compound, which interferes with two proteins to starve ...
Breast cancer–derived CTCs exhibit phenotypic plasticity, including epithelial-mesenchymal transition, subtype switching and cluster formation, which is associated with bone metastatic potential. 2.
A new antibody‑drug conjugate nearly doubles survival and extends overall survival in advanced triple‑negative breast cancer, ...
HER2-positive breast cancer exhibits marked genomic instability and heterogeneity, yet the clonal architecture and copy number variation (CNV) dynamics between ductal carcinoma in situ (DCIS) and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results